Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne

Completed · Phase 3 · Has a placebo group

Conditions studied: Acne

In brief

The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.

Key facts

Study ID

NCT01701024

Run by

Bausch Health Americas, Inc.

People needed

498

Starts

2012-10-01

Expected to finish

2013-07-01

Last updated by the study team

2018-06-04

Who can join

Age: 12 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Mobile, Alabama, United States
• Study site — Los Angeles, California, United States
• Study site — San Diego, California, United States
• Study site — New Haven, Connecticut, United States
• Study site — Aventura, Florida, United States
• Study site — Naperville, Illinois, United States
• Study site — Evansville, Indiana, United States
• Study site — South Bend, Indiana, United States
• Study site — Louisville, Kentucky, United States
• Study site — Clinton Township, Michigan, United States
• Study site — Fridley, Minnesota, United States
• Study site — Omaha, Nebraska, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — Rochester, New York, United States
• Study site — Raleigh, North Carolina, United States
• Study site — Portland, Oregon, United States
• Study site — Goodlettsville, Tennessee, United States
• Study site — Austin, Texas, United States
• Study site — College Station, Texas, United States
• Study site — Houston, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Salt Lake City, Utah, United States
• Study site — Lynchburg, Virginia, United States
• Study site — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.